Key statistics
On Friday, Tarsus Pharmaceuticals Inc (TARS:NSQ) closed at 75.52, -11.41% below its 52-week high of 85.25, set on Dec 09, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 75.75 |
|---|---|
| High | 76.92 |
| Low | 74.06 |
| Bid | -- |
| Offer | -- |
| Previous close | 75.87 |
| Average volume | 881.78k |
|---|---|
| Shares outstanding | 42.56m |
| Free float | 41.25m |
| P/E (TTM) | -- |
| Market cap | 3.21bn USD |
| EPS (TTM) | -1.61 USD |
Data delayed at least 15 minutes, as of Feb 27 2026 21:00 GMT.
More ▼
- Tarsus to Participate in Upcoming Investor Conferences
- Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements
- Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
- Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026
- Tarsus to Participate in Upcoming Investor Conference
- Tarsus to Participate in Upcoming Investor Conference
- Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements
- Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
- Tarsus to Participate in Upcoming Investor Conferences
- Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements
More ▼
